Dr. Anna Serur, MD

Dr. Serur practices at Englewood Hospital in Englewood, New Jersey, part of RWJBarnabas Health.

Dr. Serur's NPI, 1043419047, was assigned on July 11, 2007. Dr. Serur graduated from SUNY Downstate Health Sciences University in 1999. Dr. Serur's New York license number on file is 222818.

Dr. Serur's primary practice is Englewood Hospital, at 350 Engle St, Englewood, NJ 07631 in Bergen County. The practice phone is (201) 894-3000.

Dr. Serur's primary practice is Englewood Hospital in Englewood, New Jersey, part of RWJBarnabas Health. The medical group on file is Medical Associates at Englewood. Dmand AI also links Dr. Serur to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Serur practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Serur's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Serur is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Serur's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Serur treats.

CMS data shows 887 Medicare services from Dr. Serur across 15 procedure codes in 2024, for 321 Medicare patients. Medicare paid $141,523 for them.

CMS counts 321 Medicare patients who saw Dr. Serur in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Serur's median patient age at 63, with 61% women.

In 2024, Dr. Serur wrote 226 Medicare Part D claims for 115 patients. 92% of them were for generic drugs. CMS names the drug for 113 of them, across 5 drugs with 11 or more claims each, at $1,084 in total drug cost. In 2023, CMS named 86 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Serur for performance year 2024, reported through an alternative payment model (APM). Dr. Serur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 42 procedures of colonoscopy by Dr. Serur, more than 60% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Serur, published from 2003 to 2022. The most frequent topics are Mice, Nude, Neovascularization, Pathologic and Apoptosis. Dr. Serur has published most often in Int J Oncol. Dr. Serur's most frequent co-authors are Jessica Kandel, Darrell J. Yamashiro and Angela Vimbayi Kadenhe-Chiweshe, MD.

Dmand AI links Dr. Serur to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Rectal Neoplasms and Rectal Diseases.

CMS Open Payments shows 195 general payments to Dr. Serur from 41 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 36% of the total. Medtronic, Inc. paid the most, $26,415.

Dr. Serur graduated from SUNY Downstate Health Sciences University in 1999.

Dr. Serur is in network with 10 carriers, including Aetna, Elevance and Horizon Blue Cross Blue Shield of New Jersey. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.